Sixty-seven oncology physician group practices in 37 states will participate in the Enhanced Oncology Model, a voluntary five-year payment model that will begin July 1 for beneficiaries who receive systemic chemotherapy, the Centers for Medicare & Medicaid Services announced yesterday. The Center for Medicare and Medicaid Innovation model supports the administration’s moonshot goal to reduce cancer death rates by 50% over the next 25 years. Participating practices must provide 24/7 access to care, patient navigation and care planning; use certified electronic health record technology, evidence-based guidelines, electronic patient reported outcomes and data to improve quality; and must also screen for health-related social needs. The model will qualify as an alternative payment model under the Quality Payment Program’s Merit-based Incentive Payment System beginning in July. It offers two levels of downside risk, with the higher risk arrangement excluded from MIPS reporting requirements and payment adjustments as an Advanced APM. For more, see the model’s updated fact sheet.

Related News Articles

Headline
A second Senate vote on the House-passed continuing resolution to fund the federal government failed to pass Sept. 30 by a 55-45 vote, leading to a federal…
Headline
The Centers for Medicare & Medicaid Services Sept. 18 released a final rule on policy and technical changes to Medicare Advantage, the Medicare…
Headline
The AHA submitted a statement Sept. 17 for a House Ways and Means Committee markup session on a series of health care and other bills. Specifically, the AHA…
Headline
The AHA commented Sept. 12 on the Centers for Medicare & Medicaid Services calendar year 2026 physician fee schedule proposed rule. The AHA applauded CMS…
Perspective
Public
Every health care provider strives to deliver their patients the best possible care, but not all providers offer the same level or complexity of care. Current…
Headline
A Health Affairs study published Sept. 2 found that less than 40% of Medicare beneficiaries with opioid use disorder received standard care in alignment with…